Filing metadata

Accession number
0001562180-22-006641
Form type
Form 3/A
Filer
Foghorn Therapeutics Inc.
CIK
CIK 1822462
Filed
Sep 13, 2022
Reporting period
Apr 27, 2021
Description
Initial ownership

Explore SEC Filings Hub